In antitumor cellular immunity, CD8+ effector T cells kill tumor cells via toxic effector molecules (IFN-γ, perforin, and granzyme), and Th1 helps CD8+ effector T cells differentiate into effector memory cells for long-term immune memory; however, the role of Th17 cells in cancer remains controversial. The gene discussed is CD8A; the disease is cancer.